AGP Executive Report

Last update: 6 hours ago

NHS AI Rollout: England is accelerating a major AI push, including an NHS App AI triage tool to route patients to the right service and cut waiting lists, alongside AI notetaking to reduce admin. Public Health Data: The CDC reports the U.S. age-adjusted death rate hit a record low in 2025, driven in part by continued declines in overdose deaths even as influenza and pneumonia rose. Medical Innovation Policy: India’s National Medical Commission is urging medical colleges to use an ICMR-backed “Patent Mitra” initiative to patent and transfer healthcare innovations. Cell Therapy Capacity: India’s Jitendra Singh inaugurated a current good manufacturing practice facility for cellular therapy at ILBS, supporting advanced translational research and cell-based treatments. Healthcare Supply Chain Safety: Pakistan’s regulator set an Oct. 1 deadline for a barcode system to curb counterfeit medicines and plans to discontinue reusable syringes tied to HIV spread. Global Health Deal Scrutiny: Tanzania says it didn’t agree to US specimen sharing under a new health partnership, but key terms on data access and safeguards remain unclear. Clinical Research: A new review focuses on anemia and transfusion strategies for breast cancer patients receiving neoadjuvant chemotherapy, highlighting how practice varies and outcomes may differ.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
Jul. 2, 2026

Five China home medical device makers target digital healthcare growth

AGP

fallback image
Jun. 30, 2026

Sheila Bonner promoted to general manager at Kavis Pharma

AGP

fallback image
Jun. 23, 2026

PharmStars Ventures adds 11 digital health startups, grows portfolio to 23

AGP

fallback image
Jun. 25, 2026

Non-animal testing market seen tripling to $29.4 billion by 2030

AGP


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Centre Simplifies Drug Launch Process, Cuts Overcharging Liability for Pharma Companies

Centre Simplifies Drug Launch Process, Cuts Overcharging Liability for Pharma Companies

DOJ Marijuana Lawsuit Filing Cites Drug Testing Industry And Pharma Company ‘Pocketbook Interests’ In Opposing Rescheduling

DOJ Marijuana Lawsuit Filing Cites Drug Testing Industry And Pharma Company ‘Pocketbook Interests’ In Opposing Rescheduling

Killer cough syrups, zero accountability: Investigating three pharma companies

Killer cough syrups, zero accountability: Investigating three pharma companies

Peak Rock Capital Buys Asembia As Specialty Pharmacy Industry Grows

Peak Rock Capital Buys Asembia As Specialty Pharmacy Industry Grows

Doctor's method to watch England game and feel less tired on Monday

Doctor's method to watch England game and feel less tired on Monday

Colliding Forces — The Aging of the Baby Boom Generation and Contracting Nursing-Home Supply

Colliding Forces — The Aging of the Baby Boom Generation and Contracting Nursing-Home Supply

Caring for an Aging America — The Looming Crisis of the Long-Term–Care Workforce

Caring for an Aging America — The Looming Crisis of the Long-Term–Care Workforce

As featured in:

@ Journalists!

Join

No journalists yet — this is a new service area. Join today!

Journalists Wanted

fallback image
Jul. 1, 2026

TWC Introduces Healthcare Workforce Advisory Board to Support Texas’ Healthcare Industry

Texas Workforce Commission

fallback image
Jun. 29, 2026

Attor­ney Gen­er­al Ken Pax­ton Secures Near­ly $34 Mil­lion in Set­tle­ment Agree­ment with Big Phar­ma Com­pa­ny AstraZeneca for Giv­ing Ille­gal Kick­backs to Providers to Pre­scribe Its Drugs to Texans

Attorney General of Texas

fallback image
Jun. 23, 2026

Acute Kidney Injury Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

GlobeNewswire, Inc.

fallback image
Jun. 23, 2026

Evaluate Releases Annual World Preview Report Revealing Updated Market Forecasts for the Pharmaceutical Industry

GlobeNewswire, Inc.

fallback image
Jul. 4, 2026

NHS accelerates artificial intelligence rollout to cut waiting times and improve care for millions

NHS England

fallback image
Jun. 16, 2026

Slimming Grace Emphasizes Patient-Centered Healthcare in an Increasingly Automated Medical Industry

EIN Presswire

More press releases

Video Stories

YouTube video thumbnail: Why Living Past 115 Is Almost Impossible
Play
Why Living Past 115 Is Almost Impossible
YouTube video thumbnail: Danish Refugee Council on Importance of Coordinated Response to Ebola, Wider Humanitarian Crisis
Play
Danish Refugee Council on Importance of Coordinated Response to Ebola, Wider Humanitarian Crisis
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: More Life to Live: Mortality and the Drive to Make Change After a Terminal Diagnosis
Play
More Life to Live: Mortality and the Drive to Make Change After a Terminal Diagnosis
YouTube video thumbnail: Addiction and the Trauma of War: Liberia's Youth and the "Zombie Drug" Kush
Play
Addiction and the Trauma of War: Liberia's Youth and the "Zombie Drug" Kush

Video Title

Sign up for:

Medical Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Medical Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.